Solid Tumor Malignancy
13 clinical trials · Condition
◉ Watch Solid Tumor Malignancy
| Record | Firm | Date |
|---|---|---|
| Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients (NCT05164016) | St. Jude Children's Research Hospital | 2022-06-29 |
| A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy (NCT04847050) | National Cancer Institute (NCI) | 2021-04-28 |
| Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) (NCT03822117) | Incyte Corporation | 2019-10-17 |
| Selinexor Combination Ph 1 Study (NCT05177276) | Martin Gutierrez | 2014-09-01 |
| Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas (NCT00647764) | Esanex Inc. | 2008-03-01 |
Track Solid Tumor Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.